Twin Focus Capital Partners’s Bristol-Myers Squibb BMY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-5,054	Closed	-$274K	–	137
2024 Q1	$274K	Sell	5,054 -400	-7%	-$20.4K	0.05%	122
2023 Q4	$280K	Buy	5,454 +180	+3%	+$9.45K	0.06%	125
2023 Q3	$306K	Sell	5,274 -3,098	-37%	-$190K	0.07%	118
2023 Q2	$535K	Buy	8,372 +2,566	+44%	+$172K	0.11%	107
2023 Q1	$402K	Buy	5,806 +51	+0.9%	+$3.6K	0.08%	124
2022 Q4	$414K	Buy	5,755 +41	+0.7%	+$3.09K	0.09%	116
2022 Q3	$406K	Hold	5,714	–	–	0.1%	107
2022 Q2	$440K	Hold	5,714	–	–	0.1%	110
2022 Q1	$417K	Buy	5,714 +130	+2%	+$8.73K	0.08%	130
2021 Q4	$348K	Buy	5,584 +1,022	+22%	+$60K	0.07%	147
2021 Q3	$270K	Buy	4,562 +44	+1%	+$2.9K	0.06%	146
2021 Q2	$302K	Buy	+4,518	New	+$295K	0.07%	138
2021 Q1	–	Sell	-3,717	Closed	-$231K	–	164
2020 Q4	$231K	Buy	+3,717	New	+$229K	0.07%	140
2020 Q2	–	Sell	-7,795	Closed	-$434K	–	150
2020 Q1	$434K	Buy	7,795 +104	+1%	+$6.36K	0.2%	75
2019 Q4	$494K	Buy	7,691 +1,985	+35%	+$114K	0.16%	102
2019 Q3	$289K	Buy	+5,706	New	+$268K	0.11%	110